Hubei Jumpcan Pharmaceutical Co Ltd (600566) — Cash Flow Reinvestment Rate
Hubei Jumpcan Pharmaceutical Co Ltd (600566) has a Cash Flow Reinvestment Rate of 5.41x as of June 2025, reinvesting CN¥966.92 Million (capex CN¥15.27 Million plus investments CN¥-951.65 Million) from operating cash flow of CN¥178.57 Million. Check earnings quality score of Hubei Jumpcan Pharmaceutical Co Ltd to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Hubei Jumpcan Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2000–2025)
Historical reinvestment intensity for Hubei Jumpcan Pharmaceutical Co Ltd across 25 annual periods. Explore Hubei Jumpcan Pharmaceutical Co Ltd (600566) investment intensity to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Hubei Jumpcan Pharmaceutical Co Ltd (2000–2025)
Year-by-year capital reinvestment analysis for Hubei Jumpcan Pharmaceutical Co Ltd. For live market cap and broader valuation context, see how much is Hubei Jumpcan Pharmaceutical Co Ltd worth.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.82x | CN¥976.87 Million | CN¥1.20 Billion | CN¥95.86 Million | ▼ -13.1% |
| 2024 | 0.94x | CN¥2.04 Billion | CN¥2.18 Billion | CN¥174.34 Million | ▲ +366.7% |
| 2023 | 0.20x | CN¥695.87 Million | CN¥3.46 Billion | CN¥301.64 Million | ▼ -67.6% |
| 2022 | 0.62x | CN¥1.62 Billion | CN¥2.62 Billion | CN¥243.66 Million | ▲ +62.3% |
| 2021 | 0.38x | CN¥723.21 Million | CN¥1.89 Billion | CN¥248.32 Million | ▼ -55.4% |
| 2020 | 0.86x | CN¥1.53 Billion | CN¥1.78 Billion | CN¥429.63 Million | ▲ +189.4% |
| 2019 | 0.30x | CN¥635.44 Million | CN¥2.15 Billion | CN¥546.44 Million | ▼ -51.1% |
| 2018 | 0.61x | CN¥1.03 Billion | CN¥1.71 Billion | CN¥668.06 Million | ▼ -40.5% |
| 2017 | 1.02x | CN¥1.21 Billion | CN¥1.19 Billion | CN¥746.25 Million | ▲ +106.5% |
| 2016 | 0.49x | CN¥449.49 Million | CN¥913.10 Million | CN¥323.49 Million | ▼ -41.8% |
| 2015 | 0.85x | CN¥545.98 Million | CN¥645.48 Million | CN¥395.98 Million | ▲ +72.8% |
| 2014 | 0.49x | CN¥301.51 Million | CN¥616.11 Million | CN¥301.51 Million | ▼ -48.0% |
| 2013 | 0.94x | CN¥270.10 Million | CN¥287.16 Million | CN¥270.10 Million | ▼ -43.1% |
| 2012 | 1.65x | CN¥44.67 Million | CN¥27.01 Million | CN¥44.67 Million | ▼ -98.9% |
| 2011 | 147.69x | CN¥60.74 Million | CN¥411.24K | CN¥60.74 Million | ▲ +9770.9% |
| 2010 | 1.50x | CN¥76.50 Million | CN¥51.13 Million | CN¥76.50 Million | ▲ +2.4% |
| 2009 | 1.46x | CN¥7.19 Million | CN¥4.92 Million | CN¥7.19 Million | ▲ +304.4% |
| 2008 | 0.36x | CN¥8.33 Million | CN¥23.05 Million | CN¥8.33 Million | ▲ +69.4% |
| 2007 | 0.21x | CN¥7.83 Million | CN¥36.72 Million | CN¥7.83 Million | ▼ -98.3% |
| 2006 | 12.22x | CN¥51.83 Million | CN¥4.24 Million | CN¥51.83 Million | ▲ +1194.8% |
| 2005 | 0.94x | CN¥59.80 Million | CN¥63.38 Million | CN¥59.80 Million | ▼ -94.7% |
| 2003 | 17.83x | CN¥39.99 Million | CN¥2.24 Million | CN¥39.99 Million | ▲ +235.0% |
| 2002 | 5.32x | CN¥117.09 Million | CN¥22.00 Million | CN¥117.09 Million | ▼ -55.1% |
| 2001 | 11.86x | CN¥88.07 Million | CN¥7.43 Million | CN¥88.07 Million | ▲ +1349.6% |
| 2000 | 0.82x | CN¥19.41 Million | CN¥23.73 Million | CN¥19.41 Million | — |